BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 25908395)

  • 1. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner.
    Cole SR; Young GP; Byrne D; Guy JR; Morcom J
    J Med Screen; 2002; 9(4):147-52. PubMed ID: 12518003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
    Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
    Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General practitioners and colorectal cancer screening: experience in the Trentino region].
    Piffer S; Pertile R; Moretti A; Clerici M
    Ann Ig; 2011; 23(2):101-8. PubMed ID: 21770226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.
    Senore C; Ederle A; DePretis G; Magnani C; Canuti D; Deandrea S; Zorzi M; Barca A; Bestagini P; Faitini K; Bisanti L; Casale C; Ferro A; GiorgiRossi P; Quadrino F; Fiorina G; Capuano A; Segnan N; Fantin A
    Prev Med; 2015 Apr; 73():106-11. PubMed ID: 25602908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.
    Stoffel S; Benito L; Milà N; Travier N; Binefa G; Vidal C; Espinosa J; Moreno V; Garcia M
    Prev Med; 2019 Feb; 119():58-62. PubMed ID: 30594532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinvitation to screening colonoscopy: a randomized-controlled trial of reminding letter and invitation to educational meeting on attendance in nonresponders to initial invitation to screening colonoscopy (REINVITE).
    Pisera M; Kaminski MF; Kraszewska E; Rupinski M; Regula J
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):538-42. PubMed ID: 26967693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care.
    Goldshore MA; Mehta SJ; Fletcher W; Tzanis G; Doubeni CA; Paulson EC
    Am J Prev Med; 2020 Jul; 59(1):41-48. PubMed ID: 32564804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
    Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
    Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invitation letters increase participation in colorectal cancer screening - results from an observational study.
    Zhan T; Hielscher T; Bilge A; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
    Z Gastroenterol; 2017 Dec; 55(12):1307-1312. PubMed ID: 29212101
    [No Abstract]   [Full Text] [Related]  

  • 18. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
    Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
    Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
    Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study.
    Vinker S; Nakar S; Rosenberg E; Kitai E
    Isr Med Assoc J; 2002 Jun; 4(6):424-5. PubMed ID: 12073414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.